Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Baden, L.; M. El Sahly, Hana; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.; Rouphael, N.; Creech, C.; Mcgettigan, J.; Kehtan, Shishir; Segall, N.; Solís, J.; Brosz, A.; Fierro, C.; Schwartz, H.; Neuzil, K.; Corey, L.; Gilbert, P.; Janes, H.; Follmann, D.; Marovich, M.; Mascola, J.; Polakowski, L.; Ledgerwood, J.; Graham, B.; Bennett, H.; Pajon, R.; Knightly, C.; Leav, B.; Deng, W.; Zhou, Honghong; Han, Shu; Ivarsson, M.; M. Miller, Jacqueline; Zaks, T.

doi:10.1056/NEJMoa2035389

Public

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Shared by NobleBlocks on Dec 30, 2020 • 12:00 AM UTC

Authors:

L. Baden

Hana M. El Sahly

B. Essink

Abstract

Abstract Background Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the s...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!